Well-being and coping: Key aspects of unmet need of people living with glioma
These interviews highlight the unmet needs of people with glioma and their caregivers. A consistent, systematic, and focused approach to assessing the needs of glioma patients and their caregivers in the clinical setting and support for long-term adjustment is required.
Authors
- Richard Adams (ORCID: https://orcid.org/0000-0003-3915-7243)
- Annmarie Nelson (ORCID: https://orcid.org/0000-0002-6075-8425)
- Anthony Byrne (ORCID: https://orcid.org/0000-0002-1413-1496)
- Helen Bulbeck (ORCID: https://orcid.org/0000-0002-6775-5251)
- Colin Watts (ORCID: https://orcid.org/0000-0003-3531-8791)
- Ameeta Retzer (ORCID: https://orcid.org/0000-0002-4156-8386)
- Elin Baddeley (ORCID: https://orcid.org/0000-0002-7571-4820)
- Kathy Seddon
- Melanie Calvert (ORCID: https://orcid.org/0000-0002-1856-837X)
- Robin Grant
- Stephanie Sivell (ORCID: https://orcid.org/0000-0003-0253-1860)
- Olalekan Lee Aiyegbusi (ORCID: https://orcid.org/0000-0001-9122-8251)
Institutions
- Birmingham City University (GB)
- Allen Institute for Brain Science (US)
- Edinburgh Royal Infirmary (GB)
- Patient-Centered Outcomes Research Institute (US)
- National Institute for Health and Care Research (GB)
- Marie Curie Palliative Care Institute Liverpool (GB)
- Cancer Research UK Clinical Trials Unit (GB)
- NIHR Research Delivery Network (GB)
- NIHR Birmingham Biomedical Research Centre (GB)
- Marie Curie (GB)
- Cardiff University (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Neuro-Oncology Practice
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1093/nop/npae127
- Citations
- 3
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.88
Funders
- Amgen
- Pfizer
- GlaxoSmithKline
- Gilead Sciences
- Sarcoma UK
- Vertex Pharmaceuticals
- Macmillan Cancer Support
- LifeArc
- UK Research and Innovation
- Anthony Nolan
- Seagen
- National Institute for Health and Care Research
- Astellas Pharma
- Servier
- European Regional Development Fund
- Birmingham Biomedical Research Centre
- UCB Pharma
- Daiichi Sankyo Europe